3Vote!
Canadian Medicine (Free subscription) | 05/11/2009
A selection of our favourite Canadian health advisories issued over the last few days. Solubilize, nebulize, die When treating H1N1 flu patients, don't solubilize and then nebulize your powdered zanamivir (Relenza) and then put it in a ventilator. A pregnant woman died when the lactose in the powdered zanamivir combined with the liquid used to dissolve the powder and blocked her ventilator . You'll...
Explore : Board game,
Broadcasting and Entertainment,
Canada,
Diseases,
Games,
Health-Fitness,
Infectious Diseases,
Iran,
Lifestyle,
Mashad,
Medicinal Drugs,
Risk
3Vote!
Julie's Health Club (Free subscription) | 04/11/2009
Part of an ongoing series looking at the reality behind health claims THE CLAIM: Supplements, pills, inhalers, lozenges, vitamins, air sterilizers, ultraviolet lights, etc., ward off swine flu. BUYER BEWARE: Only two prescription antiviral drugs, Tamiflu and Relenza, are approved...
3Vote!
Boston Globe (Free subscription) | 03/11/2009
Norway is allowing over-the-counter sales of flu medicines Tamiflu and Relenza in response to the rapid spread of swine flu.
3Vote!
Sofia News Agency (Free subscription) | 31/10/2009
Bulgaria Deputy Health Minister, Valeri Mitrev, has reported that 127 000 doses of antiviral medicines ‘Tamiflu’ and ‘Relenza’ have been distributed to the country’s hospitals to treat swine flu. Mitrev also reported that another 200 000 doses will be bought and distributed over the coming weeks. He was speaking on a visit to Yambol Hospital, where 9 patients are reported...
5Vote!
H5N1 (Free subscription) | 30/10/2009
Via Health.com: Tamiflu-Resistant Swine Flu Passed Person-to-Person in U.S. Excerpt:So far, almost all strains of H1N1 have responded to both oseltamivir (Tamiflu) and another antiviral, zanamivir (Relenza), while displaying resistance to amantadine, a drug in a different class. As a...
3Vote!
Philadelphia Inquirer (Free subscription) | 29/10/2009
GlaxoSmithKline P.L.C. said third-quarter profit rose 30 percent after currency gains and orders for the Relenza flu drug boosted revenue. Vaccine sales declined because of a "phasing" of shipments, including swine flu shots.
3Vote!
Health - The Post Chronicle (Free subscription) | 28/10/2009
Sharply higher sales of flu drug Relenza buoyed GlaxoSmithKline's quarterly sales and the British group said it was in line for a big swine flu vaccine boost in the last three months of the year....
5Vote!
ireland.com (Free subscription) | 28/10/2009
GlaxoSmithKline's quarterly sales were boosted by strong demand for its flu drug Relenza and a weak sterling, the pharmaceutical firm said today.
3Vote!
Indy Star (Free subscription) | 28/10/2009
LONDON -- GlaxoSmithKline PLC, the world's second largest drug maker by revenue, posted Wednesday an 11 percent rise in third quarter earnings on the back of strong sales of the flu drug Relenza and forecast an even bigger boost from its swine flu vaccines in the final quarter of the year.
3Vote!
Miami Herald (Free subscription) | 28/10/2009
GlaxoSmithKline PLC, the world's second largest drug maker by revenue, posted Wednesday an 11 percent rise in third quarter earnings on the back of strong sales of the flu drug Relenza and forecast an even bigger boost from its swine flu vaccines in the final quarter of the year.
3Vote!
Examiner (Free subscription) | 28/10/2009
GlaxoSmithKline PLC, the world's second largest drug maker by revenue, posted Wednesday an 11 percent rise in third quarter earnings on the back of strong sales of the flu drug Relenza and forecast an even bigger boost from its swine flu vaccines in the final quarter of the year.
3Vote!
Seattle Times (Free subscription) | 28/10/2009
GlaxoSmithKline PLC, the world's second largest drug maker by revenue, posted Wednesday an 11 percent rise in third quarter earnings on the back of strong sales of the flu drug Relenza and forecast an even bigger boost from its swine flu vaccines in the final quarter of the year.
3Vote!
San Fransisco Chronicle (Free subscription) | 28/10/2009
GlaxoSmithKline PLC, the world's second largest drug maker by revenue, posted Wednesday an 11 percent rise in third quarter earnings on the back of strong sales of the flu drug Relenza and forecast an even bigger boost from its swine flu vaccines in the final... Sponsored Topics: GlaxoSmithKline - Swine influenza - Zanamivir - Health - Pharmaceutical industry
5Vote!
Reuters UK (Free subscription) | 28/10/2009
LONDON (Reuters) - Sharply higher sales of flu drug Relenza buoyed GlaxoSmithKline's quarterly sales and the group said it was in line for a big swine flu vaccine boost in the last three months of the year.
3Vote!
Full Comment (Free subscription) | 27/10/2009
Anyone who hasn't seen Monday night's The National — this is the new The National, where we learn Peter Mansbridge has legs — really ought to check it out, if only to witness one of the oddest moments in the history of Canadian news: Wendy Mesley, at a bookstore, wearing a sort of low-rent biohazard suit, and inquiring after an H1N1-related book. This was introduced as "a little bit...
Videos